• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实体器官移植受者中产碳青霉烯酶菌的定植与感染:一项单中心回顾性研究

Carbapenemase-Producing Colonization and Infection in Solid Organ Transplant Recipients: A Single-Center, Retrospective Study.

作者信息

Pagani Nicole, Corcione Silvia, Lupia Tommaso, Scabini Silvia, Filippini Claudia, Angilletta Roberto, Shbaklo Nour, Mornese Pinna Simone, Romagnoli Renato, Biancone Luigi, Cavallo Rossana, Di Perri Giovanni, Solidoro Paolo, Boffini Massimo, De Rosa Francesco Giuseppe

机构信息

St Stephen's Centre, Chelsea and Westminster Hospital, 252 Fulham Rd., London SW10 9NA, UK.

Department of Medical Sciences, Infectious Diseases, University of Turin, 10100 Turin, Italy.

出版信息

Microorganisms. 2021 Oct 31;9(11):2272. doi: 10.3390/microorganisms9112272.

DOI:10.3390/microorganisms9112272
PMID:34835398
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8626028/
Abstract

Carbapenemase-KPC producing (CP-Kp) infection represents a serious threat to solid organ transplant (SOT). All patients admitted between 1 May 2011 and 31 August 2014 undergoing SOT were included in the retrospective study. The primary outcomes included a description of the association of enteric colonization and invasive infections by CP- with one-year mortality. Secondary outcomes were the study of risk factors for colonization and invasive infections by CP-. Results: A total of 5.4% (45/828) of SOT recipients had at least one positive rectal swab for CP-, with most (88.9%) occurring after transplantation. 4.5% (35/828) of patients developed a CP--related invasive infection, with 68.6% (24/35) being previously colonized. The 1-year mortality was 31.1% in patients with enteric colonization with CP-Kp and, it was 51.4% among patients with CP--related invasive infections. At univariate analysis, colonization, invasive infections, sepsis, severe sepsis, and septic shock were significantly associated with 1-year mortality. At multivariate analysis, only invasive infections and the combination of sepsis, severe sepsis, or septic shock were significantly associated with 1-year mortality, whereas gastrointestinal colonization was significantly associated with survival. In this population, the 1-year mortality was significantly associated with invasive infections; otherwise, gastrointestinal colonization was not associated with increased 1-year mortality.

摘要

产碳青霉烯酶-KPC(CP-Kp)感染对实体器官移植(SOT)构成严重威胁。本回顾性研究纳入了2011年5月1日至2014年8月31日期间所有接受SOT的住院患者。主要结局包括描述CP-引起的肠道定植与侵袭性感染和1年死亡率之间的关联。次要结局是研究CP-引起的定植和侵袭性感染的危险因素。结果:共有5.4%(45/828)的SOT受者至少有一次直肠拭子检测CP-呈阳性,其中大多数(88.9%)发生在移植后。4.5%(35/828)的患者发生了与CP-相关的侵袭性感染,其中68.6%(24/35)此前已被定植。CP-Kp肠道定植患者的1年死亡率为31.1%,而与CP-相关的侵袭性感染患者的1年死亡率为51.4%。单因素分析显示,定植、侵袭性感染、脓毒症、严重脓毒症和感染性休克与1年死亡率显著相关。多因素分析显示,只有侵袭性感染以及脓毒症、严重脓毒症或感染性休克的组合与1年死亡率显著相关,而胃肠道定植与生存显著相关。在该人群中,1年死亡率与侵袭性感染显著相关;否则,胃肠道定植与1年死亡率增加无关。

相似文献

1
Carbapenemase-Producing Colonization and Infection in Solid Organ Transplant Recipients: A Single-Center, Retrospective Study.实体器官移植受者中产碳青霉烯酶菌的定植与感染:一项单中心回顾性研究
Microorganisms. 2021 Oct 31;9(11):2272. doi: 10.3390/microorganisms9112272.
2
Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in kidney transplant recipients.肾移植受者中产碳青霉烯酶肺炎克雷伯菌感染的危险因素和结局。
Infection. 2015 Jun;43(3):315-23. doi: 10.1007/s15010-015-0743-4. Epub 2015 Feb 18.
3
Comparison of Septic Shock Due to Multidrug-Resistant Acinetobacter baumannii or Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit Patients.重症监护病房患者中由耐多药鲍曼不动杆菌或产碳青霉烯酶肺炎克雷伯菌引起的感染性休克比较。
Antimicrob Agents Chemother. 2018 May 25;62(6). doi: 10.1128/AAC.02562-17. Print 2018 Jun.
4
Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case-control analysis.产肺炎克雷伯菌碳青霉烯酶(KPC)的肺炎克雷伯菌定植于肝移植受者与高感染率和额外死亡率相关:一项病例对照分析。
Infection. 2014 Apr;42(2):309-16. doi: 10.1007/s15010-013-0547-3. Epub 2013 Nov 12.
5
Risk factors for ventilator associated pneumonia due to carbapenemase-producing Klebsiella pneumoniae in mechanically ventilated patients with tracheal and rectal colonization.有气管和直肠定植的机械通气患者中,产碳青霉烯酶肺炎克雷伯菌导致呼吸机相关性肺炎的危险因素。
Minerva Anestesiol. 2016 Jun;82(6):635-40. Epub 2016 Jan 8.
6
Carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients: risk factors and predictors of mortality.重症患者产碳青霉烯酶肺炎克雷伯菌血流感染:危险因素及死亡预测因素
Eur J Clin Microbiol Infect Dis. 2017 Jul;36(7):1125-1131. doi: 10.1007/s10096-017-2899-6. Epub 2017 Jan 19.
7
KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality.产碳青霉烯酶肺炎克雷伯菌肠定植发生于 ICU 住院期间:其发展的危险因素的意义及其对死亡率的影响。
Diagn Microbiol Infect Dis. 2013 Oct;77(2):169-73. doi: 10.1016/j.diagmicrobio.2013.06.007. Epub 2013 Jul 23.
8
KPC-producing Klebsiella pneumoniae rectal colonization is a risk factor for mortality in patients with diabetic foot infections.产 KPC 肺炎克雷伯菌直肠定植是糖尿病足感染患者死亡的危险因素。
Clin Microbiol Infect. 2015 Aug;21(8):790.e1-3. doi: 10.1016/j.cmi.2015.04.010. Epub 2015 Apr 22.
9
Gut Microbiota and Clinical Features Distinguish Colonization With Carbapenemase-Producing at the Time of Admission to a Long-term Acute Care Hospital.肠道微生物群和临床特征可区分长期急性护理医院入院时产碳青霉烯酶菌的定植情况。
Open Forum Infect Dis. 2018 Jul 31;5(8):ofy190. doi: 10.1093/ofid/ofy190. eCollection 2018 Aug.
10
Epidemiology and outcome of carbapenemase-producing (KPC-KP) infections in cardiac surgery patients: a brief narrative review.心脏手术患者产碳青霉烯酶(KPC-KP)感染的流行病学与转归:简要叙述性综述
J Chemother. 2019 Nov-Dec;31(7-8):359-366. doi: 10.1080/1120009X.2019.1685794. Epub 2019 Nov 8.

引用本文的文献

1
Exploring current hypervirulent infections: insights into pathogenesis, drug resistance, and vaccine prospects.探索当前的高毒力感染:对发病机制、耐药性及疫苗前景的见解
Front Microbiol. 2025 May 29;16:1604763. doi: 10.3389/fmicb.2025.1604763. eCollection 2025.
2
Antimicrobial resistance surveillance of gram-negative bacteria among solid organ transplant recipients, a 4-year retrospective study.实体器官移植受者中革兰氏阴性菌的抗菌药物耐药性监测:一项4年回顾性研究
Sci Rep. 2025 Jun 3;15(1):19371. doi: 10.1038/s41598-025-03674-5.
3
infections after liver transplantation: Drug resistance and distribution of pathogens, risk factors, and influence on outcomes.

本文引用的文献

1
Carbapenemase producing : implication on future therapeutic strategies.产碳青霉烯酶:对未来治疗策略的影响
Expert Rev Anti Infect Ther. 2022 Jan;20(1):53-69. doi: 10.1080/14787210.2021.1935237. Epub 2021 Jun 3.
2
Novel Cephalosporins in Septic Subjects and Severe Infections: Present Findings and Future Perspective.脓毒症患者及严重感染中的新型头孢菌素:当前研究结果与未来展望
Front Med (Lausanne). 2021 May 7;8:617378. doi: 10.3389/fmed.2021.617378. eCollection 2021.
3
New cephalosporins for the treatment of pneumonia in internal medicine wards.
肝移植术后感染:病原体的耐药性与分布、危险因素及对预后的影响
World J Hepatol. 2024 Apr 27;16(4):612-624. doi: 10.4254/wjh.v16.i4.612.
4
A comprehensive evaluation of risk factors for mortality, infection and colonization associated with CRGNB in adult solid organ transplant recipients: a systematic review and meta-analysis.成人实体器官移植受者中与 CRGNB 相关的死亡率、感染和定植的危险因素的综合评估:系统评价和荟萃分析。
Ann Med. 2024 Dec;56(1):2314236. doi: 10.1080/07853890.2024.2314236. Epub 2024 Mar 5.
5
Role of the immune system in liver transplantation and its implications for therapeutic interventions.免疫系统在肝移植中的作用及其对治疗干预的影响。
MedComm (2020). 2023 Dec 13;4(6):e444. doi: 10.1002/mco2.444. eCollection 2023 Dec.
6
Epidemiology and Prevention of Early Infections by Multi-Drug-Resistant Organisms in Adults Undergoing Liver Transplant: A Narrative Review.肝移植成年患者多重耐药菌早期感染的流行病学与预防:一项叙述性综述
Microorganisms. 2023 Jun 17;11(6):1606. doi: 10.3390/microorganisms11061606.
7
Epidemic, risk factors of carbapenem-resistant infection and its effect on the early prognosis of liver transplantation.流行情况、碳青霉烯类耐药感染的危险因素及其对肝移植早期预后的影响。
Front Cell Infect Microbiol. 2022 Oct 6;12:976408. doi: 10.3389/fcimb.2022.976408. eCollection 2022.
8
Bacterial and Viral Infections in Liver Transplantation: New Insights from Clinical and Surgical Perspectives.肝移植中的细菌和病毒感染:临床与外科视角的新见解
Biomedicines. 2022 Jun 30;10(7):1561. doi: 10.3390/biomedicines10071561.
9
Ceftazidime-Avibactam as Salvage Therapy in Pediatric Liver Transplantation Patients with Infections Caused by Carbapenem-Resistant .头孢他啶-阿维巴坦作为挽救疗法用于治疗接受肝移植的儿童患者中由耐碳青霉烯类细菌引起的感染
Infect Drug Resist. 2022 Jun 25;15:3323-3332. doi: 10.2147/IDR.S369368. eCollection 2022.
10
Challenges of Antimicrobial Resistance and Stewardship in Solid Organ Transplant Patients.实体器官移植患者中抗菌药物耐药性与管理面临的挑战
Curr Infect Dis Rep. 2022;24(5):63-75. doi: 10.1007/s11908-022-00778-1. Epub 2022 Apr 30.
用于内科病房治疗肺炎的新型头孢菌素
J Thorac Dis. 2020 Jul;12(7):3747-3763. doi: 10.21037/jtd-20-417.
4
Acquisition of Carbapenemase-Producing Enterobacteriaceae in Solid Organ Transplantation Recipients.实体器官移植受者中产碳青霉烯酶肠杆菌科细菌的获得情况。
Transplant Proc. 2018 Dec;50(10):3748-3755. doi: 10.1016/j.transproceed.2018.01.058.
5
Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis.2015 年欧盟及欧洲经济区因抗生素耐药菌感染导致的死亡人数和伤残调整生命年:基于人群的模型分析。
Lancet Infect Dis. 2019 Jan;19(1):56-66. doi: 10.1016/S1473-3099(18)30605-4. Epub 2018 Nov 5.
6
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae.头孢他啶-阿维巴坦挽救治疗产碳青霉烯酶肺炎克雷伯菌引起的感染患者的疗效。
Clin Infect Dis. 2019 Jan 18;68(3):355-364. doi: 10.1093/cid/ciy492.
7
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy.碳青霉烯酶肠杆菌科在肝肺移植受者中的定植和感染及供体来源传播:意大利开展的一项前瞻性队列研究。
Clin Microbiol Infect. 2019 Feb;25(2):203-209. doi: 10.1016/j.cmi.2018.05.003. Epub 2018 May 22.
8
Does the urinary tract infection caused by carbapenem-resistant Gram-negative bacilli impact the outcome of kidney transplant recipients?耐碳青霉烯类革兰阴性杆菌引起的尿路感染会影响肾移植受者的预后吗?
Transpl Infect Dis. 2018 Aug;20(4):e12923. doi: 10.1111/tid.12923. Epub 2018 Jun 13.
9
Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study.既往由其他病原体引起的血流感染作为定植患者耐碳青霉烯类肺炎克雷伯菌血症的预测因素:一项回顾性多中心研究的结果
Eur J Clin Microbiol Infect Dis. 2017 Apr;36(4):663-669. doi: 10.1007/s10096-016-2843-1. Epub 2016 Dec 1.
10
The global epidemiology of carbapenemase-producing Enterobacteriaceae.产碳青霉烯酶肠杆菌科的全球流行病学。
Virulence. 2017 May 19;8(4):460-469. doi: 10.1080/21505594.2016.1222343. Epub 2016 Aug 11.